Comments
Loading...
Silence Therapeutics (SLN) Forecast
NewsEarningsSilence Therapeutics (SLN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Silence Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SLN | Benzinga
Explore Silence Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Silence Therapeutics (SLN) stock?
You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.
Who are Silence Therapeutics (SLN) competitors?
Other companies in Silence Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Korro Bio (NASDAQ:KRRO).
What is the forecast, or price target, for Silence Therapeutics (SLN) stock?
Silence Therapeutics has a consensus price target of $37.00.
What is the current price for Silence Therapeutics (SLN)?
The stock price for Silence Therapeutics (NASDAQ: SLN) is $3.005 last updated April 21, 2025 at 11:47 AM EDT.
Does Silence Therapeutics (SLN) pay a dividend?
There are no upcoming dividends for Silence Therapeutics.
When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?
Silence Therapeutics’s Q1 earnings are confirmed for Thursday, May 15, 2025.
Is Silence Therapeutics (SLN) going to split?
There is no upcoming split for Silence Therapeutics.
What sector and industry does Silence Therapeutics (SLN) operate in?
Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
